Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals (AVDL) Stock Price & Analysis


AVDL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.12 - $15.82
Previous Close$14.84
Average Volume (3M)935.85K
Market Cap
Enterprise Value$949.75M
Total Cash (Recent Filing)$100.92M
Total Debt (Recent Filing)$115.16M
Price to Earnings (P/E)-6.4
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.33
Shares Outstanding61,780,000
10 Day Avg. Volume697,757
30 Day Avg. Volume935,848
Standard Deviation0.28
Financial Highlights & Ratios
Price to Book (P/B)-15.84
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.19K
Enterprise Value/Gross Profit-283.93
Enterprise Value/Ebitda-10.32
Price Target Upside19.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Avadel Pharmaceuticals’s price range in the past 12 months?
Avadel Pharmaceuticals lowest stock price was $2.12 and its highest was $15.82 in the past 12 months.
    What is Avadel Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Avadel Pharmaceuticals’s upcoming earnings report date?
    Avadel Pharmaceuticals’s upcoming earnings report date is Aug 08, 2023 which is in 61 days.
      How were Avadel Pharmaceuticals’s earnings last quarter?
      Avadel Pharmaceuticals released its earnings results on May 04, 2023. The company reported -$0.48 earnings per share for the quarter, missing the consensus estimate of -$0.367 by -$0.113.
        Is Avadel Pharmaceuticals overvalued?
        According to Wall Street analysts Avadel Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Avadel Pharmaceuticals pay dividends?
          Avadel Pharmaceuticals does not currently pay dividends.
          What is Avadel Pharmaceuticals’s EPS estimate?
          Avadel Pharmaceuticals’s EPS estimate is -$0.36.
            How many shares outstanding does Avadel Pharmaceuticals have?
            Avadel Pharmaceuticals has 76,768,394 shares outstanding.
              What happened to Avadel Pharmaceuticals’s price movement after its last earnings report?
              Avadel Pharmaceuticals reported an EPS of -$0.48 in its last earnings report, missing expectations of -$0.367. Following the earnings report the stock price went up 4.982%.
                Which hedge fund is a major shareholder of Avadel Pharmaceuticals?
                Among the largest hedge funds holding Avadel Pharmaceuticals’s share is Woodline Partners LP. It holds Avadel Pharmaceuticals’s shares valued at 17M.


                  Avadel Pharmaceuticals Stock Smart Score

                  The Avadel Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Avadel Pharmaceuticals

                  Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.


                  Top 5 ETFs holding AVDL

                  Market Value
                  Smart Score
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Fidelity Nasdaq Composite Index ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold AVDL. The ETFs are listed according to market value of AVDL within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Rockwell Med
                  Palatin Technologies
                  Minerva Neurosciences
                  Achieve Life Sciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis